Aggressive Angiomyxoma

被引:112
作者
Sutton, Brian J. [1 ]
Laudadio, Jennifer [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC 27157 USA
关键词
FEMALE GENITAL-TRACT; RECURRENT DISEASE; HORMONE AGONIST; PERINEUM; VULVA; PELVIS; SERIES; ANGIOMYOFIBROBLASTOMA; IRRADIATION; NEOPLASM;
D O I
10.5858/arpa.2011-0056-RS
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Aggressive angiomyxoma is a raremesenchymal tumor that most commonly arises in the vulvovaginal region, perineum, and pelvis of women. The term aggressive emphasizes the often infiltrative nature of the tumor and its frequent association with local recurrence. Patients often present with nonspecific symptoms which are frequently misdiagnosed with more common entities, such as a Bartholin cyst, lipoma, or hernia. Histologic examination reveals a hypocellular and highly vascular tumor with a myxoid stroma containing cytologically bland stellate or spindled cells. The tumor cells are characteristically positive for estrogen and progesterone receptors, suggesting a hormonal role in the development of the tumor. Chromosomal translocation of the 12q13-15 band involving the HMGA2 gene has been described. Surgical excision is the treatment of choice, although treatment with gonadotropin-releasing hormone agonists is an emerging therapy. Metastases are exceedingly rare, and overall, the prognosis is good. (Arch Pathol Lab Med. 2012;136:217-221; doi: 10.5858/arpa.2011-0056-RS)
引用
收藏
页码:217 / 221
页数:5
相关论文
共 29 条
[1]
Aggressive angiomyxoma of the female genital tract: a clinicopathologic and immunohistochemical study of 12 cases [J].
Amezcua, C. A. ;
Begley, S. J. ;
Mata, N. ;
Felix, J. C. ;
Ballard, C. A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (01) :140-145
[2]
Aggressive angiomyxoma: A second case of metastasis with patient's death [J].
Blandamura, S ;
Cruz, J ;
Vergara, LF ;
Puerto, IM ;
Ninfo, V .
HUMAN PATHOLOGY, 2003, 34 (10) :1072-1074
[3]
Aggressive angiomyxoma in females: is radical resection the only option? [J].
Chan, IM ;
Hon, E ;
Ngai, SW ;
Ng, TY ;
Wong, LC .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (03) :216-220
[4]
Value and limitation of immunohistochemical expression of HMGA2 in mesenchymal tumors: about a series of 1052 cases [J].
Dreux, Nadege ;
Marty, Marion ;
Chibon, Frederic ;
Velasco, Valerie ;
Hostein, Isabelle ;
Ranchere-Vince, Dominique ;
Terrier, Philippe ;
Coindre, Jean-Michel .
MODERN PATHOLOGY, 2010, 23 (12) :1657-1666
[5]
Fetsch JF, 1996, CANCER-AM CANCER SOC, V78, P79, DOI 10.1002/(SICI)1097-0142(19960701)78:1<79::AID-CNCR13>3.0.CO
[6]
2-4
[7]
Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist [J].
Fine, BA ;
Munoz, AK ;
Litz, CE ;
Gershenson, DM .
GYNECOLOGIC ONCOLOGY, 2001, 81 (01) :120-122
[8]
ANGIOMYOFIBROBLASTOMA OF THE VULVA - A BENIGN NEOPLASM DISTINCT FROM AGGRESSIVE ANGIOMYXOMA [J].
FLETCHER, CDM ;
TSANG, WYW ;
FISHER, C ;
LEE, KC ;
CHAN, JKC .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (04) :373-382
[9]
Aggressive angiomyxoma: Reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases [J].
Granter, SR ;
Nucci, MR ;
Fletcher, CDM .
HISTOPATHOLOGY, 1997, 30 (01) :3-10
[10]
Aggressive angiomyxoma: A case series and literature review [J].
Haldar, K. ;
Martinek, I. E. ;
Kehoe, S. .
EJSO, 2010, 36 (04) :335-339